Trial intelligence / Profile preview

P3: Dipyridamole in Elective PCI

NCT00767663Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Oct 2008
Primary completion
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dipyridamole in myocardial reperfusion injury, sponsored by Radboud University Medical Center. Started Oct 2008; status: completed.

02

Drugs

dipyridamole
03

Conditions

myocardial reperfusion injury

Beyond the preview

Go deeper on NCT00767663.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00767663.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call